Original StudyDurvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)
Under a Creative Commons license
open access
Keywords
Exploratory analysis
Immune-checkpoint inhibitors
Patient-reported outcomes
Survival
Safety
Cited by (0)
© 2021 The Authors. Published by Elsevier Inc.